A Double-Labeling Assay for Simultaneous Estimation and Characterization of Estrogen and Progesterone Receptors using Radioiodinated Estradiol and Tritiated Org 2058

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Tumori

• Publication date

  1986-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1177/030089168607200305PMID 3739005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-performance size exclusion chromatography as a rapid method for the separation of steroid hormone receptors.

  1984cited by this paper
• Prognostic Significance of Progesterone Receptors Alone or in Association with Estrogen Receptors in Human Breast Cancer

  1984cited by this paper
• Steroid‐hormone receptors in breast cancer

  1984cited by this paper
• Criteria for the establishment of a double-labeling assay for simultaneous determination of estrogen and progesterone receptors.

  1984cited by this paper
• Double labelling assay system for oestrogen and progesterone receptors.

  1982cited by this paper
• Three radioligands compared for determining cytoplasmic estrogen-receptor content of human breast carcinomas.

  1982cited by this paper
• Assay of estradiol receptors in human breast carcinomas using the gamma emitting ligand 16 alpha [125I]iodoestradiol.

  1982cited by this paper
• 16 Alpha-[125I]-beta-estradiol compared with [3H]-beta-estradiol as the tracer in estradiol receptor assays.

  1981cited by this paper
• 14C-labeled proteins as markers for gradient analysis of steroid-hormone receptors.

  1981cited by this paper
• Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen.

  1981cited by this paper
• Simultaneous measurement of estrogen and progesterone receptors in tumor cytosols with use of 125I-labeled estradiol and of 3H-R5020.

  1981cited by this paper
• Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

  1980cited by this paper
• Interaction of 16 alpha-[125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins.

  1980cited by this paper
• The binding of progesterone, R-5020 and ORG-2058 to progesterone receptor.

  1979cited by this paper
• Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

  1978cited by this paper
• Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen.

  1978cited by this paper
• Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.

  1978cited by this paper
• Use of the vertical rotor to facilitate estrogen and progesterone receptor analysis.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Specific receptors of the steroid hormones in breast cancer.

  1974cited by this paper
• Radioactive labeling of proteins in vitro.

  1971cited by this paper
• A graphic method for the determination and presentation of binding parameters in a complex system.

  1967cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patients

  2018cites this paper
• Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trial.

  2015cites this paper
• Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients

  2015cites this paper
• miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer

  2014cites this paper
• Cell Proliferation of the Primary Tumor Predicts Ipsilateral Axillary Node Disease in Elderly Breast Cancer Patients

  2013cites this paper
• Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer

  2011cites this paper
• Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up

  2010cites this paper
• Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen

  2008cites this paper
• PIK3CA cancer mutations display gender and tissue specificity patterns

  2008cites this paper
• Relationship between ER-ICA and conventional steroid receptor assays in human breast cancer

  2005cites this paper
• Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables

  2004cites this paper
• Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?

  2003cites this paper
• Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence

  2002cites this paper
• Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer

  2001cites this paper
• Relationships between age, mammographic features and pathological tumour characteristics in non-palpable breast cancer.

  2000cites this paper
• Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women

  2000influential citation
• Time-dependent relevance of steroid receptors in breast cancer.

  2000cites this paper
• The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function

  1999cites this paper
• Relationship between Steroid Receptors (As Continuous Variables) and Response to Adjuvant Treatments in Postmenopausal Women with Node-Positive Breast Cancer

  1999cites this paper
• Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: An exploratory investigation

  1998cites this paper
• Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?

  1998cites this paper
• Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro.

  1998cites this paper
• Expression of p 53 , Glutathione S-Transferase-p , and Bcl-2 Proteins and Benefit From Adjuvant Radiotherapy in Breast Cancer

  1997cites this paper
• Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.

  1997cites this paper
• Cell proliferation in 3,800 node‐negative breast cancers: Concistency over time of biological and clinical information provided by 3H‐Thymidine labelling index

  1997cites this paper
• Receptor status variation in primary breast cancer and subsequent accessible relapse.

  1996cites this paper
• Intratumour amount of sex steroids in elderly breast cancer patients. An approach to the biological characterization of mammary tumours in the elderly.

  1996cites this paper
• Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers.

  1996cites this paper
• Combined effects of lonidamine and tamoxifen in human breast-cancer cell-lines.

  1995cites this paper
• Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus adjuvant tamoxifen.

  1995influential citation
• Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide.

  1995cites this paper
• Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.

  1995cites this paper
• Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: a retrospective study.

  1993cites this paper
• Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.

  1993cites this paper
• Estrogen and progesterone receptors in breast cancer. Immunohistochemical assay on scraping material.

  1992cites this paper
• 3H-Thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients

  1991cites this paper
• Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers.

  1991cites this paper
• Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors.

  1988cites this paper